The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: 0.00 (0.00%)
Spread: 0.50 (7.407%)
Open: 7.00
High: 7.00
Low: 6.875
Prev. Close: 7.00
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Persimmon Leads Housebuilders Higher

Tue, 21st Aug 2018 10:44

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Persimmon, up 1.3%. The housebuilder said it continued to deliver on its long-term strategy after recording a rise in first half profit and revenue. For the six months to the end of June, pretax profit totaled GBP516.5 million, up 13% from GBP457.4 million the year before, as revenue grew 5% to GBP1.84 billion from GBP1.75 billion. Persimmon said it sold 8,402 homes during the period, up from 7,794 the prior year, with the average selling price of those homes standing at GBP215,813, up 1.2% from GBP213,262. Fellow housebuilders Berkeley Group, Barratt Developments and Taylor Wimpey were up 0.8%, 0.7% and 0.5% respectively. WM Morrison Supermarkets, up 0.9% and Ocado, up 0.5%. Morrisons regained the position of fastest growing - which it had lost to Asda last month - with sales up 2.7% and market share flat at 10.4% according to data from Kantar Worldpanel. Ocado saw sales up 8.5%, as it increased its market share to 1.2% from 1.1% recorded in the year ago period. Kantar - reporting market share figures for the 12 weeks to August 12 - said branded products sales increased 3.9%, overtaking the total growth of supermarket-owned products for the first time since May 2015.----------FTSE 100 - LOSERS----------BHP Billiton, down 1.3%. The Anglo-Australian miner paid out to shareholders above its policy level, with annual profit rising though short of consensus. The total dividend for BHP's financial year was 118 cents, far higher than the 83 cents paid out a year earlier and above analyst consensus of a 116 cents return. BHP's pretax profit rose to USD14.75 billion from USD11.14 billion the prior year, while underlying earnings before interest, tax, depreciation, and amortisation was up 20% to USD23.18 billion. This excludes US shale operations, since sold off to BP, and falls short of analyst consensus of USD24.31 billion underlying Ebitda. Including US shale, the figure was USD24.11 billion. ----------FTSE 250 - WINNERS----------John Wood Group, up 6.5%. The oilfield services company swung to a loss in the first half of 2018 due to its purchase of Amec Foster Wheeler, in spite of strong revenue growth. The company swung to a pretax loss for the six months to the end of June on a proforma basis of USD25.3 million from a profit of USD13.5 million the year before, due to a one-off cost of USD101.1 million. The loss stemmed from bank fees related to the GBP2.20 billion acquisition of peer Amec Foster Wheeler, which completed in October. However, on an underlying basis, pretax profit rose to USD82.0 million from USD64.2 million. John Wood's revenue saw double digit growth, rising by 13% to USD5.38 billion from USD4.74 billion on a proforma basis the year before, due to growth in the company's Asset Solutions Business with increased capital projects activity.Aggreko, up 5.1%. HSBC upgraded the temporary power generator supplier to Buy from Hold. ----------OTHER MAIN MARKET AND AIM - WINNERS----------IXICO, up 16%. The data science company said it expects 24% jump in annual revenue, ahead of market expectations. For the year ending September 30, the data science company said it now expects revenue to be "at least" GBP5.1 million, up from GBP4.1 million a year ago, reflecting contract wins in the period. "The board expects that this will result in a reduced operating loss for the year," the company added. Looking further ahead, the company said it it confident in meeting market expectations for the year ending Septmebr 2019, as it "continues to invest in its commercially led growth strategy on the path to profitability".Tracsis, up 8.8%. The transport industry software and technology company said it expects annual revenue "ahead of market expectations" after experiencing positive momentum in all parts of the group. For the year to July 31, the company said it expects revenue at GBP40 million, up 16% from GBP34.5 million a year ago. The company added that it expects earnings before interest, taxes, depreciation and amortisation and adjusted profit to be both ahead of market expectations and ahead of the previous year, which had come in at GBP8.5 million and GBP7.7 million respectively.----------OTHER MAIN MARKET AND AIM - LOSERS----------Panthera Resources, down 25%. The gold exploration and development company noted that the government of Rajasthan has rejected the prospecting licence application made for the Bhukia joint venture in India by partner Metal Mines India. The government rejected the application due to finding the reconnaissance permit granted to Metal Mines null and void as the licence application was filed under the name Metal Mining India Ltd but the permit given to Metal Mining India Pvt Ltd. Other reasons for the rejection was a restriction in place for grant in Tibal Areas under a government order in 2000, and because the Geological Survey of India had reserved some of the land, and has expressed intentions to carry out G-2 level exploration. Panthera Resources said its joint venture has an very strong base to launch a legal challenge against the Rajasthan government to deny his rights.----------
More News
22 May 2014 12:07

IXICO Wins Contracts For Huntington's Disease Clinical Trials

LONDON (Alliance News) - Brain health company IXICO PLC Thursday said it has won contracts for two separate clinical trials in Huntington's disease with "top 15" pharmaceutical companies, building on a third clinical study already underway on the disease. In a statement, IXICO said the two

Read more
16 Apr 2014 09:54

IXICO Awarded Development Contract By NHS England Initiative

LONDON (Alliance News) - IXICO PLC Wednesday said it has been awarded a development contract by The Small Business Research Initiative for Healthcare, an NHS England initiative, to cover phase 1 funding for the development of an online application designed to support dementia sufferers after they

Read more
16 Apr 2014 07:33

UK MORNING BRIEFING: RSA Loses UK & Western Europe Chief Executive

LONDON (Alliance News) - RSA Insurance Group said Wednesday the Chief Executive of the business which houses its troubled Irish operations has resigned in order to become Executive Chairman, underwriting and distribution, at business partner A J.Gallagher. The company said UK & Western Euro

Read more
20 Mar 2014 09:19

Thursday broker round-up UPDATE

Antofagasta: Deutsche Bank cuts target price from 770p to 735p and downgrades to sell. Investec cuts target price from 753p to 726p keeping its sell recommendation. Ashmore Group: HSBC Holdings lowers target price from 410p to 400p retaining its overweight rating. Avacta Group: Numis shifts target

Read more
11 Mar 2014 15:45

Standard Chartered non-exec builds company holding after profit decline

An Independent Non-Executive Director of Standard Chartered has this week upped his stake in the group by a quarter with the purchase of 2,500 shares. John Paynter, who was appointed to his role in 2008, bought the shares at 1,246.50p each for a total of £31,163, taking his total holding to 12,50

Read more
11 Mar 2014 15:07

DIRECTOR DEALINGS: Ixico Non-Executives Buy Shares

LONDON (Alliance News) - Ixico PLC said Tuesday that non-executive chairman Andy Richards had bought 13,700 shares at 78 pence each. Non-executive director Tim Sharpington bought 12,750 shares at 78.5 pence also on Tuesday. Following these purchases Richards has a 0.2% interest in the

Read more
7 Mar 2014 14:47

IXICO, VirtualScopics In International Commercial, Operational Alliance

LONDON (Alliance News) - Brain health company IXICO PLC Friday said it has entered into an international commercial and operational alliance with VirtualScopics Inc, a quantitative medical imaging provider. "The proposed alliance will provide the clinical trials industry with global operati

Read more
28 Feb 2014 15:59

IXICO Positive On Position Following Business Transition

LONDON (Alliance News) - IXICO PLC, the company formed when IXICO Ltd and Phytopharm PLC merged, said Friday that it believes it is strongly positioned in its core clinical trials and experimental medicine markets following the transition of its business. The company formally known as Phyto

Read more
18 Nov 2013 18:34

DIRECTOR DEALINGS: IXICO Non-Executive Director Buys Shares

Read more
18 Nov 2013 18:27

IXICO Non-Executive Director Buys Shares

Read more
1 Nov 2013 16:47

DIRECTOR DEALINGS: Ixico Executive Buys Shares

Read more
31 Oct 2013 14:05

DIRECTOR DEALINGS: IXICO CEO Buys 4,000 Shares

Read more
21 Oct 2013 12:45

DIRECTOR DEALINGS: IXICO Chairman Buys Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.